Sunshine Biopharma Inc (SBFM)
0.8995
+0.03
(+3.26%)
USD |
NASDAQ |
May 14, 16:00
0.8995
0.00 (0.00%)
After-Hours: 04:11
Sunshine Biopharma Free Cash Flow (Quarterly): -2.993M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.993M |
| September 30, 2023 | -0.4691M |
| June 30, 2023 | -4.072M |
| March 31, 2023 | -2.028M |
| December 31, 2022 | -2.247M |
| September 30, 2022 | -1.124M |
| June 30, 2022 | -0.5738M |
| March 31, 2022 | -1.304M |
| December 31, 2021 | -0.3121M |
| September 30, 2021 | -0.6008M |
| June 30, 2021 | -0.6189M |
| March 31, 2021 | -0.2974M |
| December 31, 2020 | -0.4241M |
| September 30, 2020 | -0.1214M |
| June 30, 2020 | -0.082M |
| March 31, 2020 | -0.031M |
| December 31, 2019 | -0.1287M |
| September 30, 2019 | -0.0861M |
| June 30, 2019 | -0.0479M |
| March 31, 2019 | -0.234M |
| December 31, 2018 | -0.1075M |
| September 30, 2018 | -0.1759M |
| June 30, 2018 | -0.075M |
| March 31, 2018 | -0.1732M |
| December 31, 2017 | -0.2132M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.1259M |
| June 30, 2017 | -0.1001M |
| March 31, 2017 | -0.108M |
| December 31, 2016 | -0.0323M |
| September 30, 2016 | -0.063M |
| June 30, 2016 | -0.1407M |
| March 31, 2016 | -0.0816M |
| December 31, 2015 | -0.3428M |
| September 30, 2015 | -0.1026M |
| June 30, 2015 | -0.3092M |
| March 31, 2015 | -0.113M |
| December 31, 2014 | -0.2477M |
| September 30, 2014 | -0.0181M |
| June 30, 2014 | -0.182M |
| March 31, 2014 | -0.0908M |
| December 31, 2013 | -0.0397M |
| September 30, 2013 | -0.0856M |
| June 30, 2013 | -0.0993M |
| March 31, 2013 | -0.3397M |
| December 31, 2012 | -0.1728M |
| September 30, 2012 | -0.1603M |
| June 30, 2012 | -0.0252M |
| March 31, 2012 | -0.0348M |
| December 31, 2011 | -0.1178M |
| September 30, 2011 | -0.1184M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-4.072M
Minimum
Jun 2023
-0.031M
Maximum
Mar 2020
-0.9243M
Average
-0.4691M
Median
Sep 2023
Free Cash Flow (Quarterly) Benchmarks
| Lexaria Bioscience Corp | -0.6766M |
| Acasti Pharma Inc | -1.892M |
| Aurinia Pharmaceuticals Inc | 14.25M |
| Edesa Biotech Inc | -1.406M |
| Xenon Pharmaceuticals Inc | -43.37M |